Gero
PrivateLast Round
Series A
Jun 17, 2026
Total Funding Raised
$34M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Gero is a biotechnology company that utilizes a physics-informed artificial intelligence platform to analyze real-world human health data for the discovery of novel therapeutics targeting aging and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gero Comparables
Compare Gero with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Turbine | 83% | |
| Fountain Therapeutics | 82% | |
| Integrated Biosciences | 81% |
Gero Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 17, 2026 | ||||
| Series A Extension | Oct 18, 2023 | ||||
| Series A | Aug 4, 2020 | ||||
| Seed | May 1, 2019 |
Key People
Founding team and executive leadership
Gero Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TOP Venture | Series A |
| VitaDAO | Series A Extension |
| Melnichek Investments | Series A, Series A Extension |
| Bulba Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 45% MoM, from 4.4K to 6.4K.
- Jun 17, 2026
$17M raised with participation from Leonid Lozner and Melnichek Investments.
Recent news
Latest coverage and updates
- receives_financingJun 17, 2026
Gero received financing of $17M in equity financing on Jun 17th '26.
Gero Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gero's valuation, stock price, and market status.
Is Gero a public or private company?
Gero is a private company.
What is the current stock price of Gero?
Gero is a private company with no public stock price. No recent secondary market data is available.
How much is Gero worth (valuation)?
Valuation information for Gero is not publicly available.
Can I buy Gero stock?
Gero shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gero's last funding round?
Gero's most recent funding round was Series A on June 17, 2026.
Who are the main investors in Gero?
Key investors in Gero include Melnichek Investments, Bulba Ventures.
Will Gero IPO soon?
No public IPO plans have been announced for Gero.
How can I track Gero secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gero's secondary market activity and sign up for updates.